Aptus Pharma Limited (APPL): Aptus Pharma Share Price Near 52-Week High After 1.99% Dip; Stock Stays Close to Yearly Peak
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Aptus Pharma Share Price was trading at Rs 346.50 on 17 September 2026 at 2:08 PM IST, down 1.99% from the previous close of Rs 353.55. The stock remained close to its 52-week high zone after touching an intraday high of Rs 360.60 and a low of Rs 346.50. Its market capitalisation stood at Rs 606.34 Cr, keeping APPL in focus among stocks in news on Stock Market Today and Share Market Today. The latest Univest data confirms the price event but does not establish a company-specific catalyst.
For readers tracking Aptus Pharma Share Price Today, the key point is that the move reflects a near 52-week high event rather than a new record. The price action also leaves the stock well above its longer-term average reference points shown in the data, while the trading value for the latest update was Rs 0.47 Cr. In Aptus Pharma Stock News terms, the event matters because the share is trading close to its yearly high while valuation ratios remain elevated versus the sector backdrop.
Aptus Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 346.5 |
| Previous Close | Rs 353.55 |
| Today's Move | Rs -7.05 (-1.99%) |
| Open | Rs 360.6 |
| High | Rs 360.6 |
| Low | Rs 346.5 |
| Turnover | Rs 0.47 crore |
| Market Capitalisation | Rs 606.34 crore |
Aptus Pharma Limited (APPL) traded at Rs 346.5 versus the previous close of Rs 353.55, a fall of 1.99%. The stock opened at Rs 360.6, reached a high of Rs 360.6 and touched a low of Rs 346.5.
Aptus Pharma Share Price Today showed a narrow intraday spread after opening at Rs 360.60 and trading between Rs 360.60 and Rs 346.50. The last traded price was Rs 346.50, which was Rs 7.05 below the previous close of Rs 353.55. That places APPL near its 52-week high event window without implying a fresh breakout. The latest turnover was Rs 0.47 Cr, and the move can be read directly from the numbers: the stock started stronger than the final traded level and then eased to the day’s low. For investors following Aptus Pharma Share Price Live and Aptus Pharma Share Price Update, the event is simply that the stock stayed close to its yearly high while the day’s price movement remained contained within the reported range. Aptus Pharma Share Price therefore remains a stock to watch in current market news, even as the latest data does not point to a company-specific trigger.
The immediate question for Aptus Pharma Stock News is not why the stock moved, but what the price and turnover data show. They show a near-peak trading pattern, a negative day change, and a market value that remains compact in size at Rs 606.34 Cr. That is enough to keep APPL visible in 52 Week High Stocks and Market Movers discussions without converting the event into a stronger claim than the figures support.
Aptus Pharma Limited (APPL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 606.34 crore |
| P/E Ratio | 131.24x |
| P/B Ratio | 18.03x |
| ROE | 30.48% |
| ROCE | 30.01% |
| EPS | Rs 2.69 |
| Book Value Per Share | Rs 19.61 |
| Dividend Yield | 0% |
Aptus Pharma Limited (APPL) fundamental metrics show P/E 131.24x, P/B 18.03x, ROE 30.48%, ROCE 30.01%. These figures provide context only and are not a buy or sell signal.
Aptus Pharma Limited has a market capitalisation of Rs 606.34 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 131.24x, P/B at 18.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 30.48% and ROCE of 30.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.69, book value per share of Rs 19.61, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.45x, median ROE of 4.09%, median ROCE of 6.07%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 131.24x |
| Benchmark Median P/E | 13.45x |
| Benchmark Average P/E | 83.19x |
| Benchmark P/E Range | 0x to 8,715.25x |
| Company P/B Ratio | 18.03x |
| Benchmark Median P/B | 1.36x |
| Company ROE | 30.48% |
| Benchmark Median ROE | 4.09% |
| Company ROCE | 30.01% |
| Benchmark Median ROCE | 6.07% |
| Company Market Capitalisation | Rs 606.34 crore |
| Benchmark Median Market Cap | Rs 52.02 crore |
Aptus Pharma Limited (APPL) is classified under sector: Trading and industry: Trading.
Aptus Pharma Limited (APPL) has a P/E ratio of 131.24x, which is above the benchmark median of 13.45x, a difference of +875.76%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aptus Pharma Limited (APPL) has a ROE of 30.48%, which is above the benchmark median of 4.09%, a difference of +645.23%. Aptus Pharma Limited (APPL) has a ROCE of 30.01%, which is above the benchmark median of 6.07%, a difference of +394.4%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Hardwyn India Ltd. | HARDWYN | 615.42 | 50.13 | 1.45 | 2.9 | 4.3 |
| Uniphos Enterprises Ltd. | UNIENTER | 625.91 | 30.62 | 0.27 | 0.85 | 0.85 |
| Foce India Ltd. | FOCE | 587.15 | 39.23 | 6.28 | 20.11 | 19.08 |
| Shiv Aum Steels Ltd. | SHIVAUM | 639.22 | 116.52 | 5.12 | 6.08 | 8.04 |
| SK Minerals & Additives Limite | SKM | 564.33 | 31.14 | 6.7 | 60.13 | 32.3 |
Aptus Pharma Limited (APPL) has a P/E ratio of 131.24x compared with the displayed peer median of 39.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 30.48% compares with a peer median of 6.08% across the companies shown in the table. ROCE stood at 30.01% versus the displayed peer median of 8.04%, providing a capital-efficiency comparison. Aptus Pharma Limited (APPL) has a market capitalisation of Rs 606.34 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Aptus Pharma
- Aptus Pharma Share Price traded at Rs 346.50, near its 52-week high event range.
- The day change was -1.99% versus the previous close of Rs 353.55.
- Market capitalisation stood at Rs 606.34 Cr in the latest update.
- P/E of 131.24 and P/B of 18.03 place the stock above the sector medians.
- ROE of 30.48% and ROCE of 30.01% are both above the sector medians.
About Aptus Pharma
Aptus Pharma Limited (APPL) is classified in the Trading sector and Trading industry. The latest company data places it within a same-industry universe of 462 companies. Aptus Pharma Share Price therefore needs to be read alongside its sector classification, benchmark ratios and market-cap profile rather than as a standalone move. For readers following Aptus Pharma Company News and Aptus Pharma Stock Analysis, the reported figures show a listed business with elevated return ratios, a premium valuation and a compact market-cap base relative to the broader benchmark set.
Frequently Asked Questions
Why is Aptus Pharma Share Price in focus today?
Ans. Aptus Pharma Share Price is in focus because it traded at Rs 346.50, stayed near its 52-week high, and carried a market cap of Rs 606.34 Cr. The latest update confirms the price event without naming a catalyst.
What was Aptus Pharma Share Price Today?
Ans. Aptus Pharma Share Price Today was Rs 346.50, down 1.99% from the previous close of Rs 353.55. The stock also touched an intraday high of Rs 360.60 and low of Rs 346.50 during the latest update.
Is Aptus Pharma near its 52-week high?
Ans. Yes, Aptus Pharma Share Price is trading close to its 52-week high event zone. The latest price action shows the share near that yearly peak rather than at a new record, based on the reported levels.
What does Aptus Pharma market cap show?
Ans. Aptus Pharma’s market capitalisation is Rs 606.34 Cr. That places Aptus Pharma Share Price in a compact market-cap band within the Trading benchmark, where the median market cap is Rs 52.02 Cr across 462 companies.
How expensive is Aptus Pharma on valuation metrics?
Ans. Aptus Pharma Share Price carries a P/E of 131.24 and P/B of 18.03. Both are well above the sector medians of 13.45 and 1.36, which places the stock at a premium to the benchmark set.
How strong are Aptus Pharma returns on equity and capital?
Ans. Aptus Pharma reports ROE of 30.48% and ROCE of 30.01%. Both figures stand well above the Trading sector medians, showing strong return ratios in the latest data set for Aptus Pharma Share Price.
What are Aptus Pharma EPS and book value?
Ans. Aptus Pharma EPS is Rs 2.69 and book value per share is Rs 19.61. Those figures add context to Aptus Pharma Share Price by showing earnings per share and accounting net worth per share.
Can I track Aptus Pharma Share Price on Univest?
Ans. Yes. Univest tracks Aptus Pharma Share Price live along with 52-week levels, market cap, ratios, sector context and peer comparison. The stock page also carries Aptus Pharma Latest News and Aptus Pharma Stock News updates.
Track Aptus Pharma Share Price on Univest
Use Aptus Pharma Limited (APPL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Univest tracks Aptus Pharma Share Price live with market capitalisation, 52-week high levels, valuation ratios, return ratios, sector comparisons and peer context in one place. Readers can also monitor Aptus Pharma Share Price Today, Aptus Pharma Latest News, Aptus Pharma Financial Results and Aptus Pharma Share Price Update through the same stock page.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
